Login to Your Account

ID Biomedical Plans To Acquire Shire's Vaccine Unit For $120M

By Randall Osborne

Wednesday, April 21, 2004
ID Biomedical Corp. is buying the vaccines unit of Andover, UK-based Shire Pharmaceuticals Group plc for $120 million, in an arrangement that includes a loan facility of $100 million from Shire - repayable from future sales - to help get the work under way. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription